Vivalyx

Medical Devices & EquipmentSeedAachen, Germanyvivalyx.com

Latest round

Seed

Last raised

Mar 2024

Total raised

$5.8M

Investors

8

About Vivalyx

Based in Aachen, Germany, and founded in 2022 by Dr. Andreas Schumacher, Dr. Benedict Doorschodt, Prof. Dr. René Tolba, PD Dr. Christian Bleilevens, Prof. Dr.a. Vivalyx operates as an organ vitality technology company that focuses on developing and manufacturing solutions for the preservation of organs for transplantation. Vivalyx is facilitating organ preservation with its patented Omnisol solution, designed to increase organ vitality and quantity for transplantation. Omnisol offers a blood-free alternative for all preservation methods, resulting in improved clinical outcomes.

Who invested in Vivalyx

8 investors across 1 round

See all investors in Vivalyx

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Mar 26, 2024

    Amount

    $5.8M

    Investors

    Locked

Questions about Vivalyx

Who invested in Vivalyx?

Vivalyx has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Vivalyx raised?

Vivalyx has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Vivalyx last raise money?

Vivalyx's most recent round on record is a Seed, in Mar 2024.

What does Vivalyx do?

Based in Aachen, Germany, and founded in 2022 by Dr.

Where is Vivalyx headquartered?

Vivalyx is headquartered in Aachen, Germany.

Which VCs invest in companies like Vivalyx?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at Vivalyx's stage. Their profiles are linked below.

Raising like Vivalyx? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.